Moss, 12 February 2026
Gentian Diagnostics ASA ("Gentian") has today been notified that the followingtransaction has been completed by a primary insider in Gentian:
Njaal Kind, Chief Financial Officer and primary insider in Gentian, haspurchased 3,000 shares in Gentian at NOK 40.00 per share. Mr. Kind owns 29,128shares and 140,670 options after this transaction.
PDMR notification pursuant to the EU Market Abuse Regulation Article 19 isattached.
This information is subject to the disclosure requirements pursuant to Section5-12 of the Norwegian Securities Trading Act, EU Market Abuse RegulationArticle19 and Euronext Oslo Rule Book II.
For further information, please contact: Njaal Kind, Group CFO,[email protected], +47 91 90 65 25
https://newsweb.oslobors.no/message/665709